BioCentury
ARTICLE | Clinical News

Xeplion paliperidone palmitate: Phase III data

March 10, 2014 7:00 AM UTC

The open-label, international Phase III PROSIPAL trial in 715 patients with recently-diagnosed schizophrenia showed that once-monthly intramuscular injections with Xeplion for 2 years met the primary ...